[1]张少锋,李丹青,杜 凡,等.食管癌术后重症肺炎患者血清肺表面活性物质相关蛋白质-D、高迁移率族蛋白B1和中性粒细胞与淋巴细胞比值水平变化及检测意义[J].陕西医学杂志,2024,(8):1114-1117,1123.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.024]
　ZHANG Shaofeng,LI Danqing,DU Fan,et al.Changes and detection significance of serum pulmonary surfactant associated protein,high mobility group box 1 protein and neutrophil-to-lymphocyte ratioin patients with severe pneumonia after esophageal cancer surgery[J].,2024,(8):1114-1117,1123.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.024]
点击复制

食管癌术后重症肺炎患者血清肺表面活性物质相关蛋白质-D、高迁移率族蛋白B1和中性粒细胞与淋巴细胞比值水平变化及检测意义
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年8期
页码:
1114-1117,1123
栏目:
临床检验
出版日期:
2024-08-05

文章信息/Info

Title:
Changes and detection significance of serum pulmonary surfactant associated protein,high mobility group box 1 protein and neutrophil-to-lymphocyte ratioin patients with severe pneumonia after esophageal cancer surgery
作者:
张少锋; 李丹青; 杜 凡; 魏志强; 王海军
(邢台市人民医院胸外科,河北 邢台 054001)
Author(s):
ZHANG Shaofeng; LI Danqing; DU Fan; WEI Zhiqiang; WANG Haijun
(Department of Thoracic Surgery,Xingtai People's Hospital,Xingtai 054001,China)
关键词:
食管癌;  重症肺炎;  中性粒细胞与淋巴细胞比值;  肺表面活性物质相关蛋白质-D;  高迁移率族蛋白B1;  预后
Keywords:
Esophageal cancer;  Severe pneumonia;  Neutrophil-to-lymphocyte ratio;  Pulmonary surfactant associated protein;  High mobility group box 1 protein;  Prognosis
分类号:
R 735.1
DOI:
DOI:10.3969/j.issn.1000-7377.2024.08.024
文献标志码:
A
摘要:
目的:探讨中性粒细胞与淋巴细胞比值(NLR)、肺表面活性物质相关蛋白质-D(SP-D)及高迁移率族蛋白B1(HMGB1)在食管癌术后重症肺炎(SP)患者中的水平变化及检测意义。方法:选取接受手术治疗的食管癌患者257例,根据手术治疗后是否发生SP将患者分为SP组(124例)和对照组(133例)。比较两组血清SP-D、HMGB1和NLR水平。记录SP组患者28 d内预后情况,根据28 d内生存情况将SP组患者分为生存组(104例)和病死组(20例)。比较两组一般资料及实验室指标,采用Logistic回归分析食管癌术后SP患者预后影响因素。绘制受试者工作特征(ROC)曲线分析NLR、SP-D及HMGB1对食管癌术后SP患者28 d内病死风险的预测价值。结果:SP组血清SP-D及HMGB1和NLR水平高于对照组(均P<0.05)。病死组NLR、SP-D及HMGB1水平高于生存组(均P<0.05)。NLR、SP-D及HMGB1是食管癌术后SP患者病死的影响因素(均P<0.05)。NLR、SP-D及HMGB1预测食管癌术后SP患者28 d内病死风险的AUC分别为0.744、0.763、0.715,而三者联合检测的AUC更高(均P<0.05)。结论:食管癌术后SP患者NLR、SP-D及HMGB1水平升高,且与患者预后有关,三者联合检测有助于提升对患者病死风险的预测价值。
Abstract:
Objective:To investigate the changes and detection significance of neutrophil-to-lymphocyte ratio(NLR),pulmonary surfactant associated protein(SP-D)and high mobility group box 1 protein(HMGB1)in patients with severe pneumonia(SP)after esophageal cancer surgery.Methods:A total of 257 patients with esophageal cancer who underwent surgical treatment were selected.According to whether SP occurred after surgical treatment,the patients were divided into SP group(124 cases)and control group(133 cases).The levels of serum SP-D,HMGB1 and NLR were compared between the two groups.The prognosis of patients in SP group within 28 days was recorded.Patients in SP group were divided into survival group(104 cases)and death group(20 cases)according to 28-day survival.The general data and laboratory indexes of the two groups were compared.Logistic regression was used to analyze the prognostic factors of SP patients after esophageal cancer surgery.The receiver operating characteristic(ROC)curve was drawn to analyze the predictive value of NLR,SP-D and HMGB1 for the risk of death within 28 days of SP patients after esophageal cancer surgery.Results:The levels of serum SP-D,HMGB1 and NLR in the SP group were higher than those in the control group(all P<0.05).The levels of NLR,SP-D and HMGB1 in the death group were higher than those in the survival group(all P<0.05).NLR,SP-D and HMGB1 were the influencing factors for the death of SP patients after esophageal cancer surgery(all P<0.05).The AUC of NLR,SP-D and HMGB1 in predicting the mortality risk of SP patients after esophageal cancer surgery within 28 days was 0.744,0.763 and 0.715,respectively,and the AUC of the combined detection of the three was higher(all P<0.05).Conclusion:The levels of NLR,SP-D and HMGB1 in SP patients after esophageal cancer surgery are increased,and they are related to the prognosis of patients.The combined detection of the three can help to improve the predictive value for the death risk of patients.

参考文献/References:

[1] 郭学群,林洪盛.入院血清磷酸盐水平对于ICU/RICU重症肺炎患者短期病死率的预测作用[J].中国呼吸与危重监护杂志,2023,22(7):486-491.
[2] 罗松平,刘单霞,韦兆吉,等.重症肺炎行有创机械通气患者ICU死亡的多因素分析及风险模型建立[J].中国急救医学,2023,43(4):268-272.
[3] 周忠,陈默,井晓婷,等.重症肺炎患者Akt/NF-κB信号通路分子表达及其预后[J].中华医院感染学杂志,2023,33(10):1477-1481.
[4] MANNING R R,HOLCOMB R E,KATAVAMA D S,et al.Characterization of oligomer formation of surfactant protein-D(SP-D)using AF4-MALLS[J].Curr Protein Pept Sci,2022,23(12):862-873.
[5] 徐秀娟,方长太,尤青海.血清转铁蛋白受体CD71水平对重症肺炎预后的预测价值[J].郑州大学学报(医学版),2023,58(4):529-532.
[6] 中国医师协会急诊医师分会.中国急诊重症肺炎临床实践专家共识[J].中国急救医学,2016,36(2):97-107.
[7] 王鹏,宋秋鸣.预测重症肺炎患者发生鲍曼不动杆菌多重耐药的风险列线图模型建立[J].中国抗生素杂志,2022,47(4):399-404.
[8] 刘菁,王宇,汤艳芬,等.血清白细胞介素6、降钙素原在肺炎患者中的水平变化及其与肺功能的关系[J].中国感染与化疗杂志,2022,22(1):13-16.
[9] HSIEH M H,CHEN P C,HSU H Y,et al.Surfactant protein D inhibits lipid-laden foamy macrophages and lung inflammation in chronic obstructive pulmonary disease[J].Cell Mol Immunol,2023,20(1):38-50.
[10] 郭枫,乐道平,陈晶,等.乌司他丁联合美罗培南对老年重症肺炎患者炎症介质和氧化应激的影响[J].中国老年学杂志,2022,42(9):2134-2136.
[11] 董丽宏,王怡洁,朱晓琳,等.清化方对重症肺炎临床疗效及血清IL-1β、IL-13、Lac的影响[J].中华中医药学刊,2023,41(8):34-37.
[12] 冯妍,陈美元,吴建刚,等.重症肺炎患儿预后的影响因素及可溶性髓样细胞触发受体-1和高迁移率族蛋白B1对其预测价值[J].中华医院感染学杂志,2023,33(20):3146-3150.
[13] 陈建东,黄立,陈凯,等.莫西沙星注射液联合吸入性乙酰半胱氨酸治疗重症肺炎患者的临床研究[J].中国临床药理学杂志,2023,39(7):920-923.
[14] 赖文文,赵文安,张志龙,等.基于血清miRNA水平的非瓣膜性房颤患者消融术后复发风险预测列线图模型的构建与评价[J].解放军医学杂志,2023,48(6):715-722.
[15] 刘道莹,刘笛,尹昆.重症肺炎患者血清NT-proBNP和HMGB1水平的变化及其意义[J].中国现代医学杂志,2017,27(17):58-61.
[16] YAO W,WANG W,TANG W,et al.Neutrophil-to-lymphocyte ratio(NLR),platelet-to-lymphocyte ratio(PLR),and systemic immune inflammation index(SII)to predict postoperative pneumonia in elderly hip fracture patients[J].J Orthop Surg Res,2023,18(1):673.
[17] 褚明永,刘如喜,付理想,等.24 h血乳酸清除率联合NLR、PCT对重症监护病房重症肺炎28 d病死风险的预测价值分析[J].中国现代医学杂志,2023,33(17):57-61.
[18] 巩娟,张栋.血清长链非编码RNA小核仁RNA宿主基因16和miR-147a在重症肺炎患者血清中的表达及临床意义[J].陕西医学杂志,2023,52(1):75-78,82.
[19] 曹晓琳,熊琴,苏科文.经鼻高流量湿化氧疗治疗重症肺炎疗效及对患者血气指标和插管率的影响[J].陕西医学杂志,2023,52(7):871-874.
[20] 王佳,冯星火,国丽娜,等.银翘散对流感病毒感染性重症肺炎小鼠肺组织的修复机制研究[J].陕西中医,2020,41(2):156-159.
[21] 潘改燕,张妮,肖海娟.食管癌患者术后应用扶正消癌汤联合化疗治疗的临床研究[J].陕西中医,2016,37(10):1342-1343.
[22] 任春年,吴春,潘征夏,等.儿童先天性心脏病手术后重症肺炎的风险预测研究[J].第三军医大学学报,2021,43(2):109-116.
[23] SAHOO B R.Structure of fish Toll-like receptors(TLR)and NOD-like receptors(NLR)[J].Int J Biol Macromol,2020,161:1602-1617.
[24] SALVIONI L,TESTA F,SULEJMANI A,et al.Surfactant protein D(SP-D)as a biomarker of SARS-CoV-2 infection[J].Clin Chim Acta,2022,537:140-145.
[25] DONG H,ZHANG L,LIU S.Targeting HMGB1:An available therapeutic strategy for breast cancer therapy[J].Int J Biol Sci,2022,18(8):3421-3434.

相似文献/References:

[1]胡珊珊,宋 彦,罗玉明,等.食管内放射支架对中晚期食管癌患者吞咽困难疗效及预后影响[J].陕西医学杂志,2019,(1):83.
　HU Shanshan,SONG Yan,LUO Yuming,et al.Effect of esophageal stent on dysphagia and prognosis in patients with advanced esophageal cancer[J].,2019,(8):83.
[2]魏晓华,郭俊霞.不同内镜技术在食管癌及癌前病变筛查中的应用价值研究*[J].陕西医学杂志,2019,(5):591.
　WEI Xiaohua,GUO Junxia..Application value of different endoscopy techniques in the screening of esophageal cancer and precancerous lesions[J].,2019,(8):591.
[3]马显平,张海斌.叉头框转录因子M1和增殖细胞核抗原在食管癌组织中的表达及与放化疗预后相关性分析[J].陕西医学杂志,2021,50(9):1150.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.027]
　MA Xianping,ZHANG Haibin.Expression of FOXM1 and PCNA in esophageal carcinoma and their correlation with prognosis of radiotherapy and chemotherapy[J].,2021,50(8):1150.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.027]
[4]何 芸,张卫卫,孔祥云.血清白细胞介素-6、肿瘤坏死因子-α、活性氧在食管癌术后并发心房颤动患者体内表达水平及检测意义[J].陕西医学杂志,2022,51(7):816.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.011]
　HE Yun,ZHANG Weiwei,KONG Xiangyun.Expression level and significance of serum IL-6,TNF-α and reactive oxygen species in patients with atrial fibrillation after esophageal cancer surgery[J].,2022,51(8):816.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.011]
[5]张新伟,王瑞洁,张 曦,等.帕博利珠单抗联合新辅助化疗治疗Ⅱ、Ⅲ期食管癌临床疗效[J].陕西医学杂志,2022,51(7):870.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.025]
　ZHANG Xinwei,WANG Ruijie,ZHANG Xi,et al.Clinical efficacy of pembrolizumab combined with neoadjuvant chemotherapy in treatment of stage Ⅱ and Ⅲ esophageal cancer[J].,2022,51(8):870.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.025]
[6]周 敏,张艳霞,郭 楠,等.甲磺酸阿帕替尼对裸鼠食管癌的抗肿瘤作用及机制研究[J].陕西医学杂志,2023,52(12):1670.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.009]
　ZHOU Min,ZHANG Yanxia,GUO Nan,et al.Antitumor effect and mechanism of apatinib mesylate on esophageal cancer in nude mice[J].,2023,52(8):1670.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.009]
[7]易三凤,屈银宗,龚承先,等.环状RNA GRIN2B通过调控微小RNA-135b对食管癌细胞增殖和侵袭的影响实验研究[J].陕西医学杂志,2024,(3):308.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.004]
　YI Sanfeng,QU Yinzong,GONG Chengxian,et al.Effects of circular RNA GRIN2B on proliferation and invasion of esophageal cancer cells through regulation of microRNA-135b[J].,2024,(8):308.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.004]
[8]万传科,王晓霞,张彦青,等.川陈皮素对食管癌KYSE150细胞存活、侵袭和凋亡的影响及机制实验研究[J].陕西医学杂志,2024,(3):407.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.026]
　WAN Chuanke,WANG Xiaoxia,ZHANG Yanqing,et al.Effects of nobiletin on survival,invasion and apoptosis of esophageal carcinoma KYSE150 cells and its mechanism[J].,2024,(8):407.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.026]
[9]符梦婕,张 剑,李秋忆,等.长链非编码RNA淋巴细胞白血病缺失基因2/微小RNA-30c-5p/丝裂原活化蛋白激酶1轴在食管癌细胞紫杉醇耐药中的作用机制实验研究[J].陕西医学杂志,2024,(9):1155.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.001]
　FU Mengjie,ZHANG Jian,LI Qiuyi,et al.Mechanism of lncRNA DLEU2/miR-30c-5p/MAPK1 axis in paclitaxel resistance in esophageal cancer cells[J].,2024,(8):1155.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.001]
[10]王银燕,黄 翠,朱 艳,等.长链非编码RNA UBE2Q1-AS1对食管癌细胞增殖和迁移的调节作用及机制实验研究[J].陕西医学杂志,2024,(9):1172.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.004]
　WANG Yinyan,HUANG Cui,ZHU Yan,et al.Regulatory effect and mechanism of lncRNA UBE2Q1-AS1 on proliferation and migration of esophageal cancer cells[J].,2024,(8):1172.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.004]

备注/Memo

备注/Memo:
基金项目:河北省自然科学基金资助项目(H2022206546)
更新日期/Last Update: 2024-08-08